What We're Reading: Page 143
Industry reads hand-picked by our editors
Oct 22, 2021
Oct 21, 2021
Oct 20, 2021
Oct 19, 2021
-
The New York Times
F.D.A. to Allow 'Mix and Match' Approach for Covid Booster Shots
-
STAT
'Make a gesture of humanity': Pope Francis urges drug makers to release Covid-19 vaccine patents
-
The Wall Street Journal
FDA Delays Moderna Covid-19 Vaccine for Adolescents to Review Rare Myocarditis Side Effect
-
Endpoints News
With hundreds of millions spent on failed accelerated approvals, researchers call for faster FDA withdrawals
Oct 18, 2021
-
Reuters
Merck COVID-19 pill sparks calls for access for lower income countries
-
C&EN
New weight-loss drugs could shift the scales
-
Endpoints News
Vertex gets much-needed win with 'extraordinary' first patient results on potential diabetes cure
-
The Telegraph
Variant hunters: the scientists tracking Covid’s every move
Oct 15, 2021
-
The Washington Post
Biden zeroes in on Califf to head FDA as deadline nears
-
Forbes
The Inside Story Of How SoftBank-Backed Zymergen Imploded Four Months After Its $3 Billion IPO
-
The Wall Street Journal
Johnson & Johnson Places Talc Injury Claims in Bankruptcy
-
Axios
Democrats' attempt to lower private market prescription drug prices is likely to fail
Oct 14, 2021
-
Nature
‘I hope you die’: how the COVID pandemic unleashed attacks on scientists
-
STAT
Pfizer uses warranties to refund costs when cancer drug fails
-
Boston Business Journal
Scientist behind Vertex CF drugs launches new startup with Atlas
-
In The Pipeline
Molnupiravir Mutations
Previous
